🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

NeoADAURA; low ish MPR rates for mono and doublet; pCR 9% with osi mono, less for doublet; low numbers for pCR and MPR but Mayr the EFR curves are more convincing.#ASCO25

I think this suggests use of CM816 is entirely justified in this era where everyone is pushing post op continuation CPI; recruitment to ETOP-ADOPT BTOG

SWOG/NRG S1914; stopped for futility after recruiting > 400pts; more local PD in Atezo arm; clearly negative #ASCO25

ZG006; tri-specific T cell engager ; Alveltamig; ORR about 60% at both doses; much more CRS at 30mg q2w; #ASCO25

Post ASCO recovery

Just recovered from ASCO and looking forward to some F1 and cricket.

We need a piggy back Project Orbis approval this side. We have no reimbursed ex20ins EGFR reimbursed options after the mobo fail in the public health system. BTOG

Wonderful who you bump into at Lords. Good to see solid BTOG representation.

Very important adjustment to FLAURA2 reimbursement in NHS England ; allowing early initiation of TKI while the chemo gets set up. Brilliant initiative by the cancer drugs fund team. BTOG #EGFR EGFR Positive Lung Cancer UK

First time trying calla’s. Most satisfying

And there we have it. Final confirmation that F2>F1 making it the defecto SOC while we await other approvals. Great that this is reimbursed in ⁦NHS England⁩ ⁦BTOG⁩ ⁦EGFR Positive Lung Cancer UK⁩ astrazeneca.com/media-centre/p…